CRP and hepatocellular carcinoma: Scheiner et al. [7] reported that a combination of alpha-fetoprotein (AFP) and C-reactive protein (CRP) has the potential to predict HCC response to immunotherapy, termed the CRAFITY score (CRP and AFP in ImmunoTherapY).